M. A. Bregante
- Pharmacology top 5%
- Analytical Chemistry top 5%
- Molecular Medicine top 5%
- Epidemiology
- Spectroscopy
- Co-authors
- C. SolansMaria Ángeles GarcíaJ. J. AramayonaMarı́a Jesús MuñozLorenzo FraileR. Hernández del ReyAnno de JongMaría de los Ángeles García
- Topics
- Antibiotics Pharmacokinetics and Efficacy (22 papers)Analytical Methods in Pharmaceuticals (11 papers)Drug Transport and Resistance Mechanisms (7 papers)
- Journals
- TalantaXenobioticaNeonatology
In The Last Decade
M. A. Bregante
29 papers receiving 398 citations
Peers
Comparison fields: 5 of 77
- Pharmacology 295
- Analytical Chemistry 118
- Molecular Medicine 88
- Epidemiology 72
- Spectroscopy 65
Countries citing papers authored by M. A. Bregante
This map shows the geographic impact of M. A. Bregante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. A. Bregante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. A. Bregante more than expected).
Fields of papers citing papers by M. A. Bregante
This network shows the impact of papers produced by M. A. Bregante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. A. Bregante. The network helps show where M. A. Bregante may publish in the future.
Co-authorship network of co-authors of M. A. Bregante
This figure shows the co-authorship network connecting the top 25 collaborators of M. A. Bregante. A scholar is included among the top collaborators of M. A. Bregante based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. A. Bregante. M. A. Bregante is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 13 | |
| 2 | 26 | |
| 3 | 3 | |
| 4 | 20 | |
| 5 | 9 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 1 | |
| 9 | 9 | |
| 10 | 16 | |
| 11 | 4 | |
| 12 | 26 | |
| 13 | 25 | |
| 14 | 35 | |
| 15 | 25 | |
| 16 | 15 | |
| 17 | 4 | |
| 18 | 16 | |
| 19 | 37 | |
| 20 | 35 |
About M. A. Bregante
M. A. Bregante is a scholar working on Pharmacology, Molecular Medicine and Analytical Chemistry, having authored 29 papers that have together received 422 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (22 papers), Analytical Methods in Pharmaceuticals (11 papers) and Drug Transport and Resistance Mechanisms (7 papers). The work is most often cited by research in Molecular Medicine (88 citations), Pharmacology (295 citations) and Analytical Chemistry (118 citations). M. A. Bregante has collaborated with scholars based in Spain, Czechia and Germany. Frequent co-authors include C. Solans, Maria Ángeles García, J. J. Aramayona, Marı́a Jesús Muñoz, Lorenzo Fraile, R. Hernández del Rey, Anno de Jong, María de los Ángeles García, Araceli Loste Montoya and Esther Prieto. Their work appears in journals such as Talanta, Xenobiotica and Neonatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.